연구성과로 돌아가기
2024 연구성과별 연구자 정보 (1012 / 2344)
※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Document Title | Author Full Name | Author Short Name | Index | Corresponding | Address | ResearcherID | ResearcherID Author Name | ORCID | ORCID Author Name | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
| First-Line Ipatasertib, Atezolizumab, and Taxane Triplet for Metastatic Triple-Negative Breast Cancer: Clinical and Biomarker Results | Rodriguez, Jorge Luis Martinez | Rodriguez, JLM | 22 | Catholic Univ Korea, Seoul St Marys Hosp, Seoul, South Korea | p.schmid@qmul.ac.uk; | |||||
| First-Line Ipatasertib, Atezolizumab, and Taxane Triplet for Metastatic Triple-Negative Breast Cancer: Clinical and Biomarker Results | Lam, Lisa H. | Lam, LH | 23 | Genentech Inc, Prod Dev Oncol, South San Francisco, CA USA | p.schmid@qmul.ac.uk; | |||||
| First-Line Ipatasertib, Atezolizumab, and Taxane Triplet for Metastatic Triple-Negative Breast Cancer: Clinical and Biomarker Results | Jones, Surai | Jones, S | 24 | IQVIA Inc, Data Sci Safety & Med DSSM, Durham, NC USA | p.schmid@qmul.ac.uk; | |||||
| First-Line Ipatasertib, Atezolizumab, and Taxane Triplet for Metastatic Triple-Negative Breast Cancer: Clinical and Biomarker Results | Reilly, Sarah-Jayne | Reilly, SJ | 25 | Roche Prod Ltd, Welwyn Garden City, England | p.schmid@qmul.ac.uk; | |||||
| First-Line Ipatasertib, Atezolizumab, and Taxane Triplet for Metastatic Triple-Negative Breast Cancer: Clinical and Biomarker Results | Huang, Xiayu | Huang, XY | 26 | Roche China Holding Ltd, gRED Computat Sci, Pudong, Shanghai, Peoples R China | p.schmid@qmul.ac.uk; | |||||
| First-Line Ipatasertib, Atezolizumab, and Taxane Triplet for Metastatic Triple-Negative Breast Cancer: Clinical and Biomarker Results | Shah, Kalpit | Shah, K | 27 | Genentech Inc, Oncol Biomarker Dev, South San Francisco, CA USA | p.schmid@qmul.ac.uk; | |||||
| First-Line Ipatasertib, Atezolizumab, and Taxane Triplet for Metastatic Triple-Negative Breast Cancer: Clinical and Biomarker Results | Dent, Rebecca | Dent, R | 28 | Natl Canc Ctr, Singapore, Singapore | p.schmid@qmul.ac.uk; | |||||
| Five- and 10-year survival in extramammary Paget's disease: A focus on wide local excision | Ha, Dae-Lyong | Ha, DL | 1 | Kyungpook Natl Univ, Sch Med, Dept Dermatol, 130 Dongdeok Ro, Daegu 41944, South Korea | seokjong@knu.ac.kr; | |||||
| Five- and 10-year survival in extramammary Paget's disease: A focus on wide local excision | Ha, Gi Ung | Ha, GU | 2 | Kyungpook Natl Univ, Sch Med, Dept Dermatol, 130 Dongdeok Ro, Daegu 41944, South Korea | seokjong@knu.ac.kr; | |||||
| Five- and 10-year survival in extramammary Paget's disease: A focus on wide local excision | Kim, Jun Young | Kim, JY | 3 | Kyungpook Natl Univ, Sch Med, Dept Dermatol, 130 Dongdeok Ro, Daegu 41944, South Korea | seokjong@knu.ac.kr; | |||||
| Five- and 10-year survival in extramammary Paget's disease: A focus on wide local excision | Han, Man-Hoon | Han, MH | 4 | Kyungpook Natl Univ, Sch Med, Dept Pathol, Daegu, South Korea | seokjong@knu.ac.kr; | |||||
| Five- and 10-year survival in extramammary Paget's disease: A focus on wide local excision | Lee, Hyun Jung | Lee, HJ | 5 | Kyungpook Natl Univ, Sch Med, Dept Obstet & Gynecol, Daegu, South Korea | seokjong@knu.ac.kr; | |||||
| Five- and 10-year survival in extramammary Paget's disease: A focus on wide local excision | Hong, Dae Gy | Hong, DG | 6 | Kyungpook Natl Univ, Sch Med, Dept Obstet & Gynecol, Daegu, South Korea | seokjong@knu.ac.kr; | |||||
| Five- and 10-year survival in extramammary Paget's disease: A focus on wide local excision | Lee, Jeong Eun | Lee, JE | 7 | Kyungpook Natl Univ, Sch Med, Dept Radiat Oncol, Daegu, South Korea | A-5417-2013 | Lee, Joong | seokjong@knu.ac.kr; | |||
| Five- and 10-year survival in extramammary Paget's disease: A focus on wide local excision | Chung, Ho Yun | Chung, HY | 8 | Kyungpook Natl Univ, Sch Med, Dept Plast & Reconstruct Surg, Daegu, South Korea | seokjong@knu.ac.kr; |
페이지 이동: